Nifty
Sensex
:
:
23217.60
74336.45
99.00 (0.43%)
332.63 (0.45%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524516 | NSE: Not Listed

20.34
15-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  20.34
  •  20.34
  •  20
  •  19.38
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  140076
  •  2826578
  •  20.34
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 29.19
  • 44.37
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 28.63
  • N/A
  • 1.16

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 0.00%
  • 2.11%
  • 95.77%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.76
  • -3.58
  • 3.55

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 38.61

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.78
  • 11.13
  • 14.63

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -7.27
  • -4.93
  • -2.24

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Bacil Pharma - Quarterly Results
    13th Aug 2026, 00:00 AM

    Read More
  • Bacil Pharma proposes to incorporate wholly-owned subsidiary
    18th Jun 2026, 15:58 PM

    The incorporation is proposed with the objective of undertaking research and development activities and such other allied activities

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.